{"podcast":{"title":"BioSpace","slug":"biospace-6696251","podcast_index_feed_id":6696251,"rss_url":"https://api.riverside.fm/hosting/3SxyDAXU.rss","website_url":"https://www.biospace.com/","image_url":"https://hosting-media.riverside.com/media/imports/podcasts/a2a52916-bfe1-4f2a-b9a3-9be5029ecbe4/39510587-1699400129885-1e919ae7cb2aa.jpg","author":"BioSpace","episode_count":247,"summary":"Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.","last_synced_at":"2026-07-15T16:19:04.105662+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251"},"episode":{"title":"Rethinking hair loss treatment","slug":"rethinking-hair-loss-treatment","published_at":"2026-06-03T23:00:00+00:00","page_url":"https://stenobird.com/podcast/biospace-6696251/rethinking-hair-loss-treatment","show_page_url":"https://stenobird.com/podcast/biospace-6696251","url":"https://api.riverside.com/hosting-analytics/media/73d4d606e42c9a64edf4618a9552f73113027cc79b3d80f88933008281a6417c/eyJlcGlzb2RlSWQiOiJmNWQ3YmM4ZC0xNmQ0LTRmODEtOTJhOS01YTFhNTczY2JkNmEiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEyMDBiZDIxNGQ3Njg3ZjA1MDZhY2NmL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTNfXzEzLTExLTE0Lm1wMyJ9.mp3","audio_url":"https://api.riverside.com/hosting-analytics/media/73d4d606e42c9a64edf4618a9552f73113027cc79b3d80f88933008281a6417c/eyJlcGlzb2RlSWQiOiJmNWQ3YmM4ZC0xNmQ0LTRmODEtOTJhOS01YTFhNTczY2JkNmEiLCJwb2RjYXN0SWQiOiJhMmE1MjkxNi1iZmUxLTRmMmEtYjlhMy05YmU1MDI5ZWNiZTQiLCJhY2NvdW50SWQiOiI2YTE5YWE5ZTExMTVmZWU4NGJlMjI0MTUiLCJwYXRoIjoibWVkaWEvY2xpcHMvNmEyMDBiZDIxNGQ3Njg3ZjA1MDZhY2NmL2Rhbi1zYW1vcm9kbml0c2t5cy1zdHVkaW8tYTY3azAtY29tcG9zZXItMjAyNi02LTNfXzEzLTExLTE0Lm1wMyJ9.mp3","summary":"In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immunology discovery at Eli Lilly. We dive into the long-overlooked hair loss space, exploring why true innovation has lagged, how a regenerative approach aims to reactivate dormant follicles and what early proof-of-concept means for patients. Host Jennifer C. Smith-Parker , Director of Insights, BioSpace Guests Daniel Gil , CEO, Pelage Pharmaceuticals Francisco Ramírez-Valle , Senior Vice President, Immunology Discovery, Eli Lilly Disclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.","meta_description":"In this episode of Denatured, you'll be hearing from Daniel Gil, CEO of Pelage Pharmaceuticals and Francisco Ramírez-Valle, senior vice president of immun…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1305,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/biospace-6696251/episodes/rethinking-hair-loss-treatment/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/biospace-6696251/rethinking-hair-loss-treatment.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}